Seeing Is Believing
Currently out of the existing stock ratings of Robert Jones, 28 are a HOLD (37.84%), 5 are a SELL (6.76%), 41 are a BUY (55.41%).
Analyst Robert Jones, currently employed carries an average stock price target met ratio of 80% that have a potential upside of 21.52% achieved within 353 days. Previously, Robert Jones worked at BMO.
Robert Jones’s has documented 175 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALGN, Align Technology at 27-Oct-2023.
Analyst best performing recommendations are on ANTM (ANTHEM).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 4/7/2020. The price target of $40 was fulfilled within 2 days with a profit of $2.81 (7.56%) receiving and performance score of 37.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$215
$40.04 (22.89%)
$187
1 years 3 months 10 days ago
(07-Aug-2023)
14/15 (93.33%)
$28.91 (15.54%)
667
Hold
$190
$15.04 (8.60%)
$176
1 years 3 months 14 days ago
(03-Aug-2023)
7/7 (100%)
$-0.86 (-0.45%)
477
Buy
$220
$45.04 (25.74%)
$213
1 years 3 months 14 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
$215
$40.04 (22.89%)
$200
1 years 3 months 14 days ago
(03-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy
$225
$50.04 (28.60%)
$184
1 years 3 months 16 days ago
(01-Aug-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
What Year was the first public recommendation made by Robert Jones?